Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pasithea Therapeutics Corp.

NASDAQ: KTTA · Life Sciences · 3 alerts · CIK 1841330

Share price
$0.5000Close, Nov 16
Market cap
$18.4M
Shares outstanding
36.75MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pasithea Therapeutics Corp. filings on SEC EDGAR ↗

5:18 PM ET 10-Q
Financial Results

Pasithea Therapeutics Q3 2026 Results: Net Loss of $6.58M, Loss Widens

Pasithea Therapeutics Corp. reported a net loss of $14.7 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $11.1 million. The company maintained a cash position of $41.2 million as of the end of the period, down from $55.2 million at the start of the year.

Key figure
Net loss $6.58M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.